Ranitidine
Product Images NDC 10544-516

2 FDA label images from Blenheim Pharmacal, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 10544-516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 516 20) Amneal(53746 253 10) Rev0)

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 516 20) Amneal(53746 253 10) Rev0)
The image shows a packaging label for Ranitidine Tablets, USP 150 mg, manufactured by Blenheim Pharmacal, Inc. The label indicates a quantity of 20 tablets and includes storage instructions and prescription-only status. The NDC is 10544-516-20.*
FDA Label Image

Structure (Ranitidine Tablets Usp 1)

Structure (Ranitidine Tablets Usp 1)
Chemical structure of ranitidine shown, including its molecular framework with a furan ring and functional groups, visually depicting the hydrochoride (HCl) form typically used in the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.